Stocks across sectors moved sharply midday as investors digested company-specific updates ranging from new orders and earnings beats to regulatory milestones and merger chatter. Space-related names, bank shares and semiconductor stocks drew attention, while Lionsgate slid after Netflix denied interest in a potential acquisition.
Key takeaways
- SpaceX fell more than 3% after its first days as a public company after the recent IPO run-up, signaling early momentum cooling.
- Bank stocks hit fresh highs as the rally broadened, with major lenders reaching new intraday records and Citi climbing to a multi-year high.
- CarMax dropped 7% despite an earnings and revenue beat, underscoring that the market focused on post-earnings expectations after a strong prior run.
- High flyers dominated: UniQure surged nearly 75% on FDA agreement toward a gene-therapy application plan, while Aehr Test Systems and AST SpaceMobile also gained on operational updates.
- Lionsgate slid over 6% after Netflix denied reports of interest, reversing optimism that had lifted the stock earlier.
What drove the biggest moves
Bank shares extended the rally. Data from intraday trading showed the Invesco KBW Bank ETF reaching a new all-time high, as investors’ “bull market” sentiment broadened to names that had lagged. JPMorgan, Bank of America, Goldman Sachs and Morgan Stanley each touched new intraday records, while Citigroup rose to a multi-year high.
Earnings and guidance were selective catalysts. CarMax shares fell 7% after first-quarter results: the company reported earnings of $1.31 per share, above analyst expectations compiled by LSEG that called for 95 cents. The stock still had advanced 31% over the prior month, suggesting investors may have already priced in improvement ahead of results.
Jabil rose nearly 4% after fiscal third-quarter earnings and revenue topped analyst estimates. The company also issued guidance for the current quarter and full fiscal year that came in above expectations, providing a clearer near-term outlook than many investors typically see in mid-cycle updates.
Corporate actions and regulatory updates powered momentum. AST SpaceMobile gained about 2% after announcing the successful launch into orbit of three additional satellites to continue building its cellular broadband network in space. The launch used SpaceX’s Falcon 9 rocket.
UniQure surged nearly 75% after the Dutch biotech said the FDA agreed with its plan to file an application for a gene therapy to treat Huntington’s disease. The announcement directly tied to the company’s next regulatory step.
SharonAI Holdings jumped nearly 15% following a $1.6 billion private placement financing intended to fund expansion of artificial intelligence factories across Australia and the Asia-Pacific region.
At semiconductor testing and equipment names, Aehr Test Systems rose 12% after receiving a follow-on production order from a major silicon photonics customer for a fully automated wafer-level burn-in system, scheduled for delivery within six months.
Market reaction across sectors
Space and IPO momentum showed signs of cooling. SpaceX shares declined more than 3% Wednesday after surging nearly 50% over its first three days as a public company following its $135-per-share IPO last Friday. The pullback came after an outsized initial run, as early public-market momentum met profit-taking and reassessment of valuation.
Semiconductors rebound after a sell-off. Several chip-related stocks reversed Tuesday’s weakness as investors rotated back toward winners this year. Intel gained almost 4% after stating that its Intel 18A-P chip entered production, meeting its internal timeline. Advanced Micro Devices added 3%, Broadcom climbed 6% and Qualcomm rose 2%.
Coverage changes also moved individual names. Figma rallied 7% after Citigroup began research coverage with a buy rating. Citi said Figma’s total addressable market of $25 billion is still early in terms of adoption.
Meanwhile, Nano Nuclear Energy jumped 11% after Roth Capital initiated coverage with a buy rating and a price target of $45, citing increasing confidence in the commercialization pathway for its Kronos micro-modular reactor. The company’s stated modeling points to a first commercial Kronos delivery in fiscal 2030 and profitability in fiscal 2031.
Why some stocks fell despite operational progress
Lionsgate reversed earlier merger optimism. Lionsgate shares fell more than 6% after Netflix denied reports that it is interested in buying Lionsgate. That denial came after Lionsgate jumped nearly 14% on Tuesday amid potential merger talk. Netflix’s shares were down about 1% Wednesday.
CarMax’s beat wasn’t enough after a strong run. CarMax’s results outpaced analyst expectations, yet the stock still declined. Investors appeared to focus on the implications for demand and margins after the stock’s strong prior-month gains.
Sales momentum at Salesforce remained under pressure. Salesforce fell again, putting it on pace for what would be a record 12th straight decline, according to trading updates. The stock has been down 23% during the period and was last down 2%, moving to its lowest level since early 2023.
Bigger picture: what investors are watching next
With midday moves driven primarily by company-specific catalysts—earnings, guidance, regulatory progress, financing and coverage changes—investors are likely to stay focused on forward signals rather than backward beats. Attention is expected to shift next toward upcoming earnings reports and additional macro data that could influence rate expectations and risk appetite, alongside any further regulatory or deal-related developments in high-profile sectors.
